Show Search Form
registered interest | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | ||||||||||||||||||||||||||||||||||
answering body |
|
|||||||||||||||||||||||||||||||||
answering dept id | 17 | |||||||||||||||||||||||||||||||||
answering dept short name | Health | |||||||||||||||||||||||||||||||||
answering dept sort name | Health | |||||||||||||||||||||||||||||||||
hansard heading | IVF | |||||||||||||||||||||||||||||||||
house id | 1 | |||||||||||||||||||||||||||||||||
legislature |
|
|||||||||||||||||||||||||||||||||
question text | To ask the Secretary of State for Health, how much was spent by his Department on the provision of in-vitro fertilisation in each year since 2010. | |||||||||||||||||||||||||||||||||
tabling member constituency | Liverpool, Wavertree | |||||||||||||||||||||||||||||||||
tabling member printed |
|
|||||||||||||||||||||||||||||||||
uin | 228777 | |||||||||||||||||||||||||||||||||
answer |
|
|||||||||||||||||||||||||||||||||
tabling member |
|
registered interest | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | ||||||||||||||||||||||||||||||||||
answering body |
|
|||||||||||||||||||||||||||||||||
answering dept id | 17 | |||||||||||||||||||||||||||||||||
answering dept short name | Health | |||||||||||||||||||||||||||||||||
answering dept sort name | Health | |||||||||||||||||||||||||||||||||
hansard heading | IVF | |||||||||||||||||||||||||||||||||
house id | 1 | |||||||||||||||||||||||||||||||||
legislature |
|
|||||||||||||||||||||||||||||||||
question text | To ask the Secretary of State for Health, pursuant to the Answer of 25 February 2015 to Question 224828, what assessment he has made of the factors contributing to the reduction in NHS-funded IVF cycles from 2013 to 2014. | |||||||||||||||||||||||||||||||||
tabling member constituency | Liverpool, Wavertree | |||||||||||||||||||||||||||||||||
tabling member printed |
|
|||||||||||||||||||||||||||||||||
uin | 227135 | |||||||||||||||||||||||||||||||||
answer |
|
|||||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the remarks by Earl Howe on 24 February (HL Deb, col 1622) and the Written Answer by Earl Howe on 9 March (HL5132), for how many years the Human Fertilisation and Embryology Authority (HFEA) has been advising them on the drafting of regulations for proposed interventions for mitochondrial disease; what are the reasons for the current delay in the HFEA announcing its proposals for the regulation, monitoring and reporting of mitochondrial donation treatment cycles; whether it is still their view that "further delay would not be doing the right the thing for families who desperately want to have the choice to access these new techniques"; if so, how delays due to the HFEA have already been explained to such families; and whether they will be able to announce publication of the HFEA’s proposals for regulation, monitoring and reporting in advance of the next General Election. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5620 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 10 February (HL4443) and 9 March (HL5132), to what extent miscarriages and stillbirths are considered by the HFEA to be abnormalities; and when they will place in the Library of the House a full copy of the correspondence between the member of the HFEA’s Expert Panel and the Zhang research group. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5621 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government to what extent Council Directive 93/42 EEC of 14 June 1993 concerning medical devices and Directive 98/79 EEC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices applies to items such as IVF laboratory equipment or reagents where there is no intention to place such items on the market; how it is possible for a fertility clinic to obtain CE marking for items that they do not intend to place on the market for the purposes of HFEA licence condition T30; and what consideration is given to the quality, safety and efficacy of in-house products that conform to the highest clinical standards and which demonstrably exceed those of marketed equivalents. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5622 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 25 February (HC224623) and the Written Answer by Earl Howe on 6 March (HL5131), how and why the Medicines and Healthcare Products Regulatory Agency (MHRA) was notified by the Human Fertilisation and Embryology Authority (HFEA) that manufacturers were making non-CE-marked reagents available on 4 December 2013 and 23 November 2014 if the MHRA is not notified of individual instances as reported in HFEA inspection reports; and what are the alternative CE-marked products that the clinics in question had subsequently given a commitment to use. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5505 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 26 January (HL4228), why multiple letters submitted to the Mitochondria Review Policy Team at the Human Fertilisation and Embryology Authority (HFEA) that are included as non-confidential written evidence submitted to the HFEA’s Expert Panel in 2011 were addressed to Ms Hannah Darby; in what capacity Ms Darby had been employed by either the HFEA or the Expert Panel; whether such evidence was received by Ms Darby on behalf of Authority members, the HFEA Executive or the HFEA’s Expert Panel; why Ms Darby had also personally written to the Medicines and Healthcare products Regulatory Agency (MHRA); whether the information solicited from the MHRA was for the benefit of Authority members, the HFEA Executive or the HFEA’s Expert Panel; who was the Senior Policy Officer at the HFEA to whom Dr David Keefe had written on 24 March 2014; why the personal identity of that addressee had been redacted from non-confidential evidence submitted in 2014; and how the addressing of all such correspondence reflects how the Expert Panel has been independent of the HFEA. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5506 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 24 February (HL4892), whether they have identified any other speculative accounts in the media of the likely timetable for the first mitochondrial donation cycle, based on the research shared on a confidential basis with the Human Fertilisation and Embryology Authority (HFEA) Expert Panel; and what steps they and the HFEA have taken in order to ensure that the general public are properly informed of the speculative nature of such accounts. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5362 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 6 January (HL3422) and the remarks by Earl Howe on 24 February (HL Deb, col 1621), why there is no universally agreed definition of genetic modification in humans if there is not "a scientifically based alternative" to the working definition devised by the Chief Medical Officer; and how other countries have hitherto proceeded without such a working definition. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5364 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|
registered interest | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
date | |||||||||||||||||||||||||||||||
answering body |
|
||||||||||||||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||||||||||||||
answering dept short name | Health | ||||||||||||||||||||||||||||||
answering dept sort name | Health | ||||||||||||||||||||||||||||||
hansard heading | IVF | ||||||||||||||||||||||||||||||
house id | 2 | ||||||||||||||||||||||||||||||
legislature |
|
||||||||||||||||||||||||||||||
question text | To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 20 February (HL4711) and the Written Answer by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 25 February (HC224623), what criteria are used by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Human Fertilisation and Embryology Authority (HFEA) in determining whether the modification of an embryo culture medium by a clinician prior to its use with permitted gametes or embryos and their ensuing introduction into patients would be considered as the manufacture of a new medical device; and whether the MHRA is notified of individual instances as reported in HFEA inspection reports when the users and manufacturers of such products would accordingly be considered as the same individuals. | ||||||||||||||||||||||||||||||
tabling member printed |
|
||||||||||||||||||||||||||||||
uin | HL5365 | ||||||||||||||||||||||||||||||
answer |
|
||||||||||||||||||||||||||||||
tabling member |
|